Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impact of Hyperferritinemia on the Outcome of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies

  • Barba, Pere|||0000-0001-7076-7969
  • Valcárcel, David|||0000-0002-8747-078X
  • Pérez-Simón, José Antonio|||0000-0003-3616-6101
  • Fernandez Aviles, Francesc|||0000-0003-3051-3926
  • Piñana, José Luis|||0000-0001-8533-2562
  • Martino Bofarull, Rodrigo|||0000-0001-5143-4042
  • López-Anglada, Lucía|||0000-0003-1727-8546
  • Rovira Argelagués, Montserrat|||0000-0001-7786-9079
  • García Cadenas, Irene|||0000-0002-2994-9055
  • Novelli, Silvana|||0000-0001-8750-0195
  • Carreras, Enric|||0000-0002-3134-9964
  • López Corral, Lucia|||0000-0003-1908-5596
  • Sierra, Jorge|||0000-0002-7966-0356
Hyperferritinemia has been associated with adverse outcomes after allogeneic hematopoietic cell transplantation (allo-HCT) with myeloablative conditioning. However, its characteristics and impact on the outcome in the reduced-intensity conditioning (RIC) and in the lymphoid malignancy settings are far from clear. The study includes 201 adult patients undergoing allo-HCT with RIC (allo-RIC) for lymphoid malignancies with a median follow-up for survivors of 52 months (range, 3 to 123). Median serum ferritin level at allo-RIC was 379 ng/mL (range, 4 to 10,790). In the multivariate analysis, patients with hyperferritinemia at transplantation (.